Submitted by Anonymous (not verified) on 11 March 2026 - 10:46
Human medicines European public assessment report (EPAR): Kirsty (previously Kixelle), insulin aspart, Date of authorisation: 05/02/2021, Revision: 6, Status: Authorised
Source: